These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21865887)

  • 1. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.
    Tremblay C; St-Amour I; Schneider J; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):788-98. PubMed ID: 21865887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.
    Ohta Y; Tremblay C; Schneider JA; Bennett DA; Calon F; Julien JP
    Acta Neuropathol Commun; 2014 Apr; 2():37. PubMed ID: 24690380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
    Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Wuu J; Mathis CA; Scheff SW; Mufson EJ; DeKosky ST
    Neurology; 2011 Jul; 77(1):39-47. PubMed ID: 21700583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of TDP-43 in Alzheimer's Disease.
    Chang XL; Tan MS; Tan L; Yu JT
    Mol Neurobiol; 2016 Jul; 53(5):3349-3359. PubMed ID: 26081142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment.
    Assaraf MI; Diaz Z; Liberman A; Miller WH; Arvanitakis Z; Li Y; Bennett DA; Schipper HM
    J Neuropathol Exp Neurol; 2007 May; 66(5):389-98. PubMed ID: 17483696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease.
    Mufson EJ; He B; Nadeem M; Perez SE; Counts SE; Leurgans S; Fritz J; Lah J; Ginsberg SD; Wuu J; Scheff SW
    J Neuropathol Exp Neurol; 2012 Nov; 71(11):1018-29. PubMed ID: 23095849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old.
    Carlos AF; Sekiya H; Koga S; Gatto RG; Casey MC; Pham NTT; Sintini I; Machulda MM; Jack CR; Lowe VJ; Whitwell JL; Petrucelli L; Reichard RR; Petersen RC; Dickson DW; Josephs KA
    J Neuropathol Exp Neurol; 2023 Dec; 83(1):36-52. PubMed ID: 38086178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
    Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
    Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clinical, Genetic, and Pathologic Features of Limbic and Diffuse Transactive Response DNA-Binding Protein 43 Pathology in Alzheimer's Disease Neuropathologic Spectrum.
    Carlos AF; Machulda MM; Rutledge MH; Nguyen AT; Reichard RR; Baker MC; Rademakers R; Dickson DW; Petersen RC; Josephs KA
    J Alzheimers Dis; 2023; 93(4):1521-1535. PubMed ID: 37182869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 in aging and Alzheimer's disease - a review.
    Wilson AC; Dugger BN; Dickson DW; Wang DS
    Int J Clin Exp Pathol; 2011 Jan; 4(2):147-55. PubMed ID: 21326809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 pathology, cognitive decline, and dementia in old age.
    Wilson RS; Yu L; Trojanowski JQ; Chen EY; Boyle PA; Bennett DA; Schneider JA
    JAMA Neurol; 2013 Nov; 70(11):1418-24. PubMed ID: 24080705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.
    Woltjer RL; Duerson K; Fullmer JM; Mookherjee P; Ryan AM; Montine TJ; Kaye JA; Quinn JF; Silbert L; Erten-Lyons D; Leverenz JB; Bird TD; Pow DV; Tanaka K; Watson GS; Cook DG
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):667-76. PubMed ID: 20535038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
    Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
    Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of Aβ-dependent and independent pathways on TDP-43 proteinopathy in Alzheimer's disease: a possible connection to LATE-NC.
    Jamerlan A; An SSA
    Neurobiol Aging; 2020 Nov; 95():161-167. PubMed ID: 32814257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.